Minerva Surgical, Inc.
UTRS
$0.00
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 3.11% | 4.52% | 1.35% | -3.47% | -3.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.11% | 4.52% | 1.35% | -3.47% | -3.60% |
| Cost of Revenue | 5.56% | 7.61% | 4.30% | 6.82% | 6.23% |
| Gross Profit | 1.12% | 2.09% | -0.89% | -10.75% | -10.32% |
| SG&A Expenses | -5.50% | 9.92% | 8.39% | 14.53% | 22.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.14% | 10.11% | 7.46% | 11.71% | 15.96% |
| Operating Income | 6.93% | -18.70% | -16.60% | -39.25% | -60.25% |
| Income Before Tax | -95.88% | -319.72% | -98.02% | -58.94% | 55.88% |
| Income Tax Expenses | 488.89% | 455.56% | 22.22% | 22.22% | -- |
| Earnings from Continuing Operations | -96.08% | -319.85% | -97.98% | -58.93% | 55.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -96.08% | -319.85% | -97.98% | -58.93% | 55.85% |
| EBIT | 6.93% | -18.70% | -16.60% | -39.25% | -60.25% |
| EBITDA | 2.01% | -30.99% | -24.09% | -61.25% | -111.03% |
| EPS Basic | 12.19% | 37.23% | 85.86% | 93.72% | 98.14% |
| Normalized Basic EPS | -36.43% | -119.68% | -11.66% | 89.02% | 97.82% |
| EPS Diluted | 12.19% | 37.23% | 85.86% | 93.72% | 98.14% |
| Normalized Diluted EPS | -36.43% | -119.68% | -11.66% | 89.02% | 97.82% |
| Average Basic Shares Outstanding | 348.12% | 307.32% | 230.48% | 309.19% | 1,315.58% |
| Average Diluted Shares Outstanding | 348.12% | 307.32% | 230.48% | 309.19% | 1,315.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
